Common use of Additional Commitments Regarding Additional Products Clause in Contracts

Additional Commitments Regarding Additional Products. As Noven performs its technical feasibility work, the product candidates will be evaluated by the parties against Endo's clinical development criteria. Endo will determine whether an Additional Product will move into pilot studies within *** of receiving from Noven its feasibility evaluation. Once Endo has determined that an Additional Product will move into pilot studies, Endo will conduct pilot studies on the successful candidates ***. Within *** days of the completion of human pharmacokinetic studies on each Additional Product that has been nominated for pilot studies, Endo will determine whether such Additional Product will move into full clinical development. If Endo determines that an Additional Product is to move into final clinical work then the parties will negotiate a Commercialization Agreement pursuant to Section 8.03 below. Endo will move each nominated Additional Product for which a Commercialization Agreement is entered into between the Parties into full clinical development. If Endo at any time makes a final decision not to advance an Additional Product into pilot studies or nominate it for full clinical development, Noven shall be thereafter free to develop, license and/or commercialize such compound for its own benefit. Noven agrees to work with Endo in good faith to provide additional information to aid Endo in making its determination of whether to move each Additional Product into pilot studies and thereafter into full clinical development . Endo agrees to work with Noven in good faith in determining whether to move each Additional Product into pilot studies and thereafter into full clinical development.

Additional Commitments Regarding Additional Products. As Noven performs its technical feasibility work, the product candidates will be evaluated by the parties against Endo's clinical development criteria. Endo will determine whether an Additional Product will move into pilot studies within *** of receiving from Noven its feasibility evaluation. Once Endo has determined that an Additional Product will move into pilot studies, Endo will conduct pilot studies on the successful candidates ***. Within *** days of the completion of human pharmacokinetic studies on each Additional Product that has been nominated for pilot studies, Endo will determine whether such Additional Product will move into full clinical development. If Endo determines that an Additional Product is to move into final clinical work then the parties will negotiate a Commercialization Agreement pursuant to Section 8.03 below. Endo will move each nominated Additional Product for which a Commercialization Agreement is entered into between the Parties into full clinical development. If Endo at any time makes a final decision not to advance an Additional Product into pilot studies or nominate it for full clinical development, Noven shall be thereafter free to develop, license and/or commercialize such compound for its own benefit. Noven agrees to work with Endo in good faith to provide additional information to aid Endo in making its determination of whether to move each Additional Product into pilot studies and thereafter into full clinical development . Endo agrees to work with Noven in good faith in determining whether to move each Additional Product into pilot studies and thereafter into full clinical development.